Axon Therapy— 510(k) K233364
Substantially EquivalentNeuralace Medical, Inc.
FDA 510(k) clearance K233364 for Axon Therapy, Substantially Equivalent on 2024-01-10. Applicant: Neuralace Medical, Inc.. Device class: 2.
Clearance details
- Applicant
- Neuralace Medical, Inc.
- Product code
- Code QPL
- Device class
- Class 2
- Regulation
- 21 CFR 882.5890
- Advisory panel
- Neurology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- San Diego, CA, US
Recent devices under product code QPL
view allData sourced from openFDA. This site is unofficial and independent of the FDA.